GILD Financial Facts
Provision for income taxes: 951MShares used in per share calculation - diluted: 1.34B
See Full Income Statement
Other accrued liabilities: 3.48B
Long-term income taxes payable: 1.62B
See Full Balance Sheet
Gilead Sciences Inc. (GILD) Earnings
|
Expand Research on GILD
| Next EPS Date | 4/25/24 | EPS Growth Rate | +13.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.9% | Revenue Growth Rate | -0.6% |
| Average % Move 1-Wk after EPS | -3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/25/11  |
 |
Q410 | $0.95 | $0.94 | +$0.01 | $2B | $1.99B | N/A |  | | Details |
| 10/27/22 | Q322 | $1.90 | $1.52 | +$0.38 | $7B | $6.13B | = | | | Details | |
| 7/26/12 |
|
Q212 | $0.99 | $0.95 | +$0.04 | $2.41B | $2.29B | N/A | | | Details |
| 2/2/12 |
|
Q411 | $0.97 | $1.05 | -$0.08 | $2.2B | $2.18B | N/A | | | Details |
| 8/3/23 | Q223 | $1.34 | $1.65 | -$0.31 | $6.6B | $6.45B | = | | | Details | |
| 2/2/23 | Q422 | $1.67 | $1.50 | +$0.17 | $7.4B | $6.66B | = | | | Details | |
| 7/28/15 |
|
Q215 | $3.15 | $2.71 | +$0.44 | $8.24B | $7.61B | = | | | Details |
| 2/2/16 |
|
Q415 | $3.32 | $3.00 | +$0.32 | $8.51B | $8.13B | = | | | Details |
